NEW YORK:: Johnson & Johnson reported quarterly earnings well above expectations, as strong sales of new drugs offset weak demand for consumer products and medical devices, and the company slightly raised its full-year profit view.
J&J on Tuesday said it earned US$4.73bill, or US$1.64 per share, in the first quarter. That compared with US$3.5bil, or US$1.22 per share, in the year-ago quarter, when the diversified healthcare company took a big litigation charge.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!